Inventor · disambiguated record
Mark Karbarz
Also filed as: KARBARZ MARK
4 granted patents·5 pending applications·8 citations·filing 2013–2023
68Inventor score
Top patents by PatentIndex Score
9 records- 0194US10954504B2Preparation of factor Xa derivativesALEXION PHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·14 claims
- 0287US11845966B2Preparation of factor Xa derivativesALEXION PHARMA INC·Filed 2021·Granted Dec 19, 2023·1 cites·13 claims
- 0383US2024076642A1Preparation of factor xa derivativesALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 0482US10604748B2Preparation of factor Xa derivativesPORTOLA PHARM INC·Filed 2017·Granted Mar 31, 2020·3 cites·27 claims
- 0567US2021379163A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 0663US2015352194A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 0763US2018333469A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 0854US12115154B2Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)SRX CARDIO LLC·Filed 2020·Granted Oct 15, 2024·0 cites·7 claims
- 0951US2022267269A1Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9)SRX CARDIO LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Karbarz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →